1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Skin Cancer Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Skin Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Skin Cancer Diagnostics Market Regional Analysis
6.2 Europe Skin Cancer Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Europe Skin Cancer Diagnostics Market Forecast Analysis
7. Europe Skin Cancer Diagnostics Market Analysis – by Type
7.1 Melanoma and Non-Melanoma
- 7.1.1 Overview
- 7.1.2 Melanoma and Non-Melanoma: Europe Skin Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Skin Cancer Diagnostics Market Analysis – by Screening Type
8.1 Blood Tests
- 8.1.1 Overview
- 8.1.2 Blood Tests: Europe Skin Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Dermatoscopy
- 8.2.1 Overview
- 8.2.2 Dermatoscopy: Europe Skin Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Imaging Tests
- 8.3.1 Overview
- 8.3.2 Imaging Tests: Europe Skin Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Lymph Node Biopsy
- 8.4.1 Overview
- 8.4.2 Lymph Node Biopsy: Europe Skin Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Skin Biopsy
- 8.5.1 Overview
- 8.5.2 Skin Biopsy : Europe Skin Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Skin Cancer Diagnostics Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Skin Cancer Diagnostics Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 Europe Skin Cancer Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 UK: Europe Skin Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.1.2 UK: Europe Skin Cancer Diagnostics Market Breakdown, by Screening Type
- 9.2.1.2 Germany:
Europe Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Germany: Europe Skin Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.2.2 Germany: Europe Skin Cancer Diagnostics Market Breakdown, by Screening Type
- 9.2.1.3 France:
Europe Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 France: Europe Skin Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.3.2 France: Europe Skin Cancer Diagnostics Market Breakdown, by Screening Type
- 9.2.1.4 Russia:
Europe Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Russia: Europe Skin Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.4.2 Russia: Europe Skin Cancer Diagnostics Market Breakdown, by Screening Type
- 9.2.1.5 Italy:
Europe Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.5.1 Italy: Europe Skin Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.5.2 Italy: Europe Skin Cancer Diagnostics Market Breakdown, by Screening Type
- 9.2.1.6 Rest of Europe:
Europe Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Skin Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.6.2 Rest of Europe: Europe Skin Cancer Diagnostics Market Breakdown, by Screening Type
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 SkylineDx BV
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 AMLo Biosciences Limited
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 DermLite LLC
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 NeraCare GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 F. HOFFMANN-LA ROCHE LTD
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 bioMerieux SA
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Michelson Diagnostics Ltd.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Europe Skin Cancer Diagnostics Market
